Table 3.
Association between saliva IL-17A levels and recipient IL17A genotypes (n = 34).
Days | Genotype |
n
valid& |
IL-17A median |
Minimum levels |
Maximum levels |
P* | |
---|---|---|---|---|---|---|---|
Blood levelsa | +35 | GG | 14 | 22.42 | 0.00 | 849.80 | 0.007 |
AG | 13 | 49.25 | 0.00 | 480.14 | |||
AA | 11 | 0.00 | 0.00 | 39.56 | |||
+100 | GG | 8 | 3.59 | 0.00 | 178.00 | NS | |
AG | 12 | 0.00 | 0.00 | 116.00 | |||
AA | 8 | 0.00 | 0.00 | 44.02 | |||
| |||||||
Saliva levelsb | +35 | GG | 10 | 0.00 | 0.00 | 5.78 | NS |
AG | 10 | 1.62 | 0.00 | 21.74 | |||
AA | 9 | 0.00 | 0.00 | 11.12 | |||
+100 | GG | 9 | 0.00 | 0.00 | 27.00 | NS | |
AG | 8 | 0.76 | 0.00 | 54.12 | |||
AA | 7 | 0.00 | 0.00 | 21.23 |
NS: not significant; A: absent; P: present; *Kruskal Wallis test; apg/mL; bpg/mg protein.
&Number of valid samples in each moment.